As developing countries upgrade their regulatory systems, they should focus on closing legal gaps that put consumers at risk and undermine market credibility. In China, for example, the manufacturers of pharmaceutical ingredients can dodge drug regulation by claiming that their products will be used for non-medical purposes.
在发展中国家升级监管体系的时，它们应该关注消除让消费者面临风险、破坏市场信誉的法律空白。比如，在中国，药物成分制造商可以通过宣称产品为非药用用途规避药品监管。即使信誉卓著的企业能确保所有原料的质量，这一漏洞也足以导致不安全产品流入市场，比如，2008年至少81名美国人死于含有不合格中国原料的血液稀释肝素。